Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-24 @ 10:58 PM
NCT ID:
NCT05743569
Eligibility Criteria:
Inclusion Criteria:
1. Over the age of 18
2. Biopsy-confirmed mucosal head and neck cancer. All histologic malignancies will be included.
3. Patients who have completed primary tumor surgical resection in the following anatomic subsites:
1. oral cavity (oral tongue, floor of mouth, hard palate, buccal mucosa, retromolar trigone, maxillary and mandibular alveolus, lip)
2. oropharynx (soft palate, base of tongue, palatine tonsils)
3. hypopharynx (piriform sinus, post-cricoid, posterior pharyngeal wall)
4. larynx (supraglottic, glottic, subglottic);
4. Patients who have consented to 3D specimen mapping on protocol IRB # 221597 and for whom 3D specimen maps are therefore available.
5. Patients are indicated to receive curative-intent post-operative radiotherapy and intend to receive radiotherapy at Vanderbilt University Medical Center or Vanderbilt Ingram Cancer Center sites in Nashville, Franklin, or Lebanon
Exclusion Criteria:
1. Under the age of 18
2. Cutaneous malignancies
3. Characteristics that make the process of informed consent questionable
4. Pregnant women
5. Patients with contraindications to radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
28 Years
Study:
NCT05743569
Study Brief:
Protocol Section:
NCT05743569